Comparison

Prion PrP (27-30) N-terminal Peptide

Item no. 06-511-248705
Manufacturer GENWAY
Amount 1 mg
Category
Type Peptides
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias GWB-1F5CF6
Similar products 06-511-248705
Available
Genway ID:
GWB-1F5CF6
Specificity:
Prion PrP (27-30) N-terminal Peptide
Type of Product:
Purified Neuroscience Reagents
Inactivation:
Not applicable.
Buffer:
Not applicable. Applications Notes : Specific methodologies have not been tested using this product. Prion PrP (27-30) N-terminal Peptide. Prion Protease Resistant Protein (PrP) MW 27-30kDa N-terminal Peptide
Function:
The physiological function of PrP is not known.
Subunit:
PrP has a tendency to aggregate yielding polymers called \" rods\" . Interacts with GRB2 PRNPIP and SYN1 (By similarity).
Subcellular Location:
Cell membrane; Lipid-anchor GPI-anchor. Golgi apparatus (By similarity).
Ptm:
The glycosylation pattern (the amount of mono- di- and non-glycosylated forms or glycoforms) seems to differ in normal and CJD prion.
Polymorphism:
The five tandem octapeptide repeats region is highly unstable. Insertions or deletions of octapeptide repeat units are associated to prion disease.
Disease:
PrP is found in high quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) fatal familial insomnia (FFI) Gerstmann-Straussler disease (GSD) Huntington disease-like 1 (HDL1) and kuru in humans; scrapie in sheep and goat; bovine spongiform encephalopathy (BSE) in cattle; transmissible mink encephalopathy (TME); chronic wasting disease (CWD) of mule deer and elk; feline spongiform encephalopathy (FSE) in cats and exotic ungulate encephalopathy (EUE) in nyala and greater kudu. The prion diseases illustrate three manifestations of CNS degeneration: (1) infectious (2) sporadic and (3) dominantly inherited forms. TME CWD BSE FSE EUE are all thought to occur after consumption of prion-infected foodstuffs.
Disease:
Defects in PRNP are the cause of Creutzfeldt-Jakob disease (CJD) [MIM:123400]. CJD occurs primarily as a sporadic disorder (1 per million) while 10-15% are familial. Accidental transmission of CJD to humans appears to be iatrogenic (contaminated human growth hormone (HGH) corneal transplantation electroencephalographic electrode implantation etc. ). Epidemiologic studies have failed to implicate the ingestion of infected annimal meat in the pathogenesis of CJD in human. The triad of microscopic features that characterize the prion diseases consists of (1) spongiform degeneration of neurons (2) severe astrocytic gliosis that often appears to be out of proportion to the degree of nerve cell loss and (3) amyloid plaque formation. CJD is characterized by progressive dementia and myoclonic seizures affecting adults in mid-life. Some patients present sleep disorders abnormalities of high cortical function cerebellar and corticospinal disturbances. The disease ends in death after a 3-12 months illness.
Disease:
Defects in PRNP are the cause of fatal familial insomnia (FFI) [MIM:600072]. FFI is an autosomal dominant disorder and is characterized by neuronal degeneration limited to selected thalamic nuclei and progressive insomnia.
Disease:
Defects in PRNP are the cause of Gerstmann-Straussler disease (GSD) [MIM:137440]. GSD is a heterogeneous disorder and was defined as a spinocerebellar ataxia with dementia and plaquelike deposits. GSD incidence is less than 2 per 100 million live births.
Disease:
Defects in PRNP are the cause of Huntington disease-like 1 (HDL1) [MIM:603218]. HDL1 is an autosomal dominant early onset neurodegenerative disorder with prominent psychiatric features.
Disease:
Defects in PRNP are the cause of kuru [MIM:245300]. Kuru is transmitted during ritualistic cannibalism among natives of the New Guinea highlands. Patients exhibit various movement disorders like cerebellar abnormalities rigidity of the limbs and clonus. Emotional lability is present and dementia is conspicuously absent. Death usually occurs from 3 to 12 month after onset.
Disease:
Defects in PRNP are the cause of prion disease with protracted course [MIM:606688]; an autosomal dominant presenile dementia with a rapidly progressive and protracted clinical course. The dementia was characterized clinically by frontotemporal features including early personality changes. Some patients had memory loss several showed aggressiveness hyperorality and verbal stereotypy others had parkinsonian symptoms.
Similarity:
Belongs to the prion family.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close